wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38543802-4792DDA5-2C54-4A1A-B200-A043F341A43B
Q38543802-4792DDA5-2C54-4A1A-B200-A043F341A43B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38543802-4792DDA5-2C54-4A1A-B200-A043F341A43B
A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epi
P2860
Q38543802-4792DDA5-2C54-4A1A-B200-A043F341A43B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38543802-4792DDA5-2C54-4A1A-B200-A043F341A43B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e7b4cb157bf985bfe4503654eb30e6695d556a1
P2860
Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients.